Interview with Graziella Pellegrini – Using stem cells to cure blindness

Professor Graziella Pellegrini is one of the principal scientists on the ground breaking, corneal repair system Holoclar ®.  Working throughout Italy over the past 27 years she is now based at the Centre for Regenerative Medicine “Stefano Ferrari” at the University of Modena and Reggio Emilia. 

Interview with Michele De Luca – Epithelial cells and regrowing corneal epithelium

Michele de Luca began his stem cell research career working in Boston in the 80s, after training as an endocrinologist.  Alongside Professor Howard Green he worked with epithelial stem cells for the treatment of patients with burns to the skin, before moving back to Italy.  He is director of the Centre for Regenerative Medicine "Stefano Ferrari" at the University of Modena and Reggio Emilia.

Europe approves Holoclar®, the first stem cell-based medicinal product

The European Commission has given Holoclar®, the first advanced therapy medicinal product (ATMP) containing stem cells, conditional marketing authorisation following a recommendation for approval by the European Medicines Agency.

Retinal regeneration

Retinal regeneration

The eye and stem cells: the path to treating blindness

Ultimo aggiornamento:
20 Ago 2012

Sight is arguably our most important sense; we rely upon it to navigate through our surroundings with ease. Loss of vision can have a huge impact on a person’s life, but many of the disorders that cause blindness are currently difficult or impossible to treat. Researchers are now using stem cell technology to explore possible new approaches to treatments for loss of vision.

Condividi contenuti